Current evidence of COVID-19 vaccination-related cardiovascular events

Area of Science:

• Cardiology
• Vaccinology
• Public Health

Background:

• The COVID-19 pandemic necessitated rapid vaccine development and deployment.
• Post-vaccination surveillance identified rare cardiovascular adverse events.
• Understanding these events is crucial for maintaining vaccine confidence and public health.

Purpose of the Study:

• To review the etiology, pathophysiology, clinical features, and management of cardiovascular adverse events following COVID-19 vaccination.
• To provide an updated overview of conditions such as myocarditis, pericarditis, and thrombosis with thrombocytopenia syndrome.
• To emphasize the importance of differentiating vaccine-related events from other causes.

Main Methods:

• Comprehensive literature review of reported cardiovascular adverse events associated with COVID-19 vaccines.
• Analysis of data on myocarditis, pericarditis, thrombosis with thrombocytopenia syndrome, myocardial infarction, arrhythmias, hypertension, and stress-induced cardiomyopathy.
• Synthesis of current understanding regarding diagnosis and management strategies.

Main Results:

• COVID-19 vaccines are associated with a range of cardiovascular adverse events, including myocarditis and pericarditis.
• The overall benefits of COVID-19 vaccination substantially exceed the risks of these rare adverse events.
• Diagnostic scoring systems and therapeutic approaches are needed for effective management.

Conclusions:

• While rare, cardiovascular adverse events following COVID-19 vaccination require careful monitoring and management.
• Continued research is essential for developing safer vaccines and refining vaccination strategies.
• Public health recommendations emphasize the continued importance of COVID-19 vaccination.